Flawed preprint based on autopsies inadequate to demonstrate that COVID-19 vaccines caused 74% of those deaths - Health Feedback
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial - The Lancet Regional Health – Americas
For Authors: Submit your work
Preprints with The Lancet: joining online research discussion platforms - The Lancet
The Lancet Respiratory Medicine Home Page
Prepublication and clinical practice: challenges ahead
Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility - The Lancet Global Health
A new paradigm is needed to explain long COVID - The Lancet Respiratory Medicine
For Authors: Submit your work
Reporting and data sharing level for COVID-19 vaccine trials: A cross-sectional study - eBioMedicine
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly - The Lancet
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
The Lancet Infectious Diseases, January 2024, Volume 24, Issue 1, Pages 1-106, e1-e69
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases
The Lancet Commission on lessons for the future from the COVID-19 pandemic - The Lancet
For Authors: Submit your work
The Lancet on X: "NEW—Most reliable estimates to date suggest 1 in 8 COVID-19 patients develop #longCOVID symptoms. https://t.co/wechj5flvg https://t.co/pT8lBAWS4g" / X
First Look - SSRN | Elsevier
Many scientists citing two scandalous COVID-19 papers ignore their retractions | Science | AAAS
Robustness of evidence reported in preprints during peer review - The Lancet Global Health
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression - The Lancet Infectious Diseases
The Lancet Regional Health – Americas
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study - The Lancet Infectious Diseases
